Studies on Low-Dose Oral Contraceptives: Cervical Mucus and Plasma Hormone Changes in Relation to Circulating D-Norgestrel and 17α-Ethynyl Estradiol Concentrations
- 1 August 1976
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 27 (8), 892-899
- https://doi.org/10.1016/s0015-0282(16)42008-x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Plasma Levels of Progesterone and Oestrogens in Women Treated with an Oral Contraceptive of Low Oestrogen Content (Ovostat 1375)Acta Obstetricia et Gynecologica Scandinavica, 1975
- Some aspects of the use of 125I-labelled ligands for steroid radioimmunoassayJournal of Steroid Biochemistry, 1974
- Inhibition of ovulation by means of a combined preparation with reduced amounts of active substanceContraception, 1974
- Effects of a Low-oestrogen Oral Contraceptive on Urinary Excretion of Luteinizing Hormone and Ovarian SteroidsBMJ, 1974
- PLASMA LEVELS OF ETHYNYLOESTRADIOL AFTER ADMINISTRATION OF ETHYNYLOESTRADIOL OR MESTRANOL TO HUMAN SUBJECTSJournal of Endocrinology, 1973
- Clinical Assessment of Low Oestrogen Combined Oral ContraceptiveBMJ, 1973
- Some observations on the measurement of estradiol-17β in human plasma by radioimmunoassaySteroids, 1972
- ZUM STOFFWECHSEL VON NORETHISTERON (17α-ÄTHINYL-4-ÖSTREN-17β-OL-3-ON) UND DL- SOWIE D-NORGESTREL (18-METHYL-17α-ÄTHINYL-4-ÖSTREN-17β-OL-3-ON) BEIM MENSCHENActa Endocrinologica, 1971
- THE SECRETION OF IMMUNO-REACTIVE LUTEINIZING HORMONE AND FOLLICLE-STIMULATING HORMONE BY THE HUMAN FOETAL PITUITARY IN ORGAN CULTUREJournal of Endocrinology, 1971